MHB088C for advanced extrapulmonary neuroendocrine cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called MHB088C for people with advanced neuroendocrine cancer that started outside the lungs. It is for those who have already tried platinum-based chemotherapy and need another option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of advanced neuroendocrine cancer that started outside the lungs and cannot be removed by surgery or has spread.
- You have already tried at least one round of platinum-based chemotherapy (like cisplatin or carboplatin) and it didn't work or you couldn't tolerate it.
- You are between 18 and 80 years old.
- You are generally active and able to take care of yourself (ECOG score 0 or 1).
- Your liver, kidney, and blood cell counts are adequate based on blood tests.
- You do not have poorly controlled brain metastases, active infections, or serious heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
This trial tests a combination of two experimental drugs, MHB088C and MHB039A, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors and help patients live longer.
This trial tests an injection called MHB118C for people with advanced solid tumors that have stopped responding to standard treatments or have no standard options. The goal is to see if this new drug can help shrink tumors or slow their growth.
This early-stage study tests an investigational drug (MHB088C) in adults with advanced or metastatic solid cancers that have gotten worse or can’t be treated with standard options. It aims to see if the drug is safe and can shrink tumors or control the cancer.
This trial tests a new drug called MHB009C for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective.
This trial tests a new drug called MHB042C for people with advanced solid tumors that have stopped responding to other treatments. It aims to see if the drug is safe and effective.
Hear when a new Advanced Extrapulmonary Neuroendocrine Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.